These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Patient information and consent in trials for the treatment of benign prostatic obstruction. Thorpe AC; Neal DE BJU Int; 2000 Mar; 85 Suppl 1():42-5. PubMed ID: 10756705 [No Abstract] [Full Text] [Related]
5. The Prostate Trials Office research protocols. Yang Q; Donovan J; Abrams P BJU Int; 2000 Mar; 85 Suppl 1():58-65. PubMed ID: 10756708 [No Abstract] [Full Text] [Related]
6. Clinically and Statistically Significant Changes Seen in Sham Surgery Arms of Randomized, Controlled Benign Prostatic Hyperplasia Surgery Trials. Welliver C; Kottwitz M; Feustel P; McVary K J Urol; 2015 Dec; 194(6):1682-7. PubMed ID: 26143113 [TBL] [Abstract][Full Text] [Related]
8. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial. Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Concomitant OAB and BPH. Moss MC; Rezan T; Karaman UR; Gomelsky A Curr Urol Rep; 2017 Jan; 18(1):1. PubMed ID: 28092069 [TBL] [Abstract][Full Text] [Related]
10. Moxibustion as an adjuvant for benign prostatic hyperplasia with lower urinary tract symptoms: a protocol for a parallel-group, randomised, controlled pilot trial. Lee HY; Nam JK; Lee SD; Lee DH; Han JY; Yun YJ; Lee JH; Park HL; Park SH; Kwon JN BMJ Open; 2015 Dec; 5(12):e008338. PubMed ID: 26656981 [TBL] [Abstract][Full Text] [Related]
12. Combined medical treatment using dutasteride and tamsulosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Djavan B; Handl MJ; Dianat S Expert Opin Pharmacother; 2010 Oct; 11(15):2535-47. PubMed ID: 20854184 [TBL] [Abstract][Full Text] [Related]
13. Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia. Yokoyama O; Ozeki A; Suzuki N; Murakami M Int J Urol; 2018 Mar; 25(3):240-245. PubMed ID: 29094398 [TBL] [Abstract][Full Text] [Related]
14. Invasive and minimally invasive treatment modalities for lower urinary tract symptoms: what are the relevant differences in randomised controlled trials? Tubaro A; Vicentini C; Renzetti R; Miano L Eur Urol; 2000; 38 Suppl 1():7-17. PubMed ID: 11111204 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo-controlled clinical studies. Oelke M; Wagg A; Takita Y; Büttner H; Viktrup L BJU Int; 2017 May; 119(5):793-803. PubMed ID: 27988986 [TBL] [Abstract][Full Text] [Related]
16. Benign prostatic hyperplasia. Melville A; Donovon J; Sheldon T; Peters T Qual Health Care; 1996 Jun; 5(2):111-9. PubMed ID: 10158589 [No Abstract] [Full Text] [Related]
17. Comparative effects of Yi Jin Jing versus Tai Chi exercise training on benign prostatic hyperplasia-related outcomes in older adults: study protocol for a randomized controlled trial. Liu X; Huang G; Chen P; Li Y; Xiang J; Chen T; Wang R Trials; 2016 Jul; 17(1):319. PubMed ID: 27422168 [TBL] [Abstract][Full Text] [Related]
18. A review of studies published during 1998 examining the treatment and management of benign prostatic obstruction. Frymann R; Cranston D; O'Boyle P BJU Int; 2000 Mar; 85 Suppl 1():46-53. PubMed ID: 10756706 [No Abstract] [Full Text] [Related]